LXR-1035

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameLXR-1035
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsMyocardial InfarctionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLxr Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLxr Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionStroke

Other Information

ATC CodeN/A
Related LinksN/A